These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11243422)

  • 41. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wall stress-induced arrhythmias in the working rat heart as left ventricular hypertrophy regresses during captopril treatment.
    Dalton GR; Jones JV; Evans SJ; Levi AJ
    Cardiovasc Res; 1997 Mar; 33(3):561-72. PubMed ID: 9093526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmias.
    Guo D; Young L; Wu Y; Belardinelli L; Kowey PR; Yan GX
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1375-81. PubMed ID: 20190097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Olmesartan medoxomil reverses left ventricle hypertrophy and reduces inflammatory cytokine IL-6 in the renovascular hypertensive rats.
    Li ZC; Yu HY; Wang XX; Zhang M; Wang JP
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3318-22. PubMed ID: 24379062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term treatment of spontaneously hypertensive rats with PD123319 and electrophysiological remodeling of left ventricular myocardium.
    Ying X; Kai-Pan G; Wei-Qing L; Long-Yun P; De-Xi W; Zhi-Bin H
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1333-1340. PubMed ID: 27629578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardioprotective effect of angiotensin II receptor antagonists.
    White M
    Can J Cardiol; 1999 Nov; 15 Suppl F():10F-4F. PubMed ID: 10579747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockade of renin-angiotensin system prevents micturition dysfunction in renovascular hypertensive rats.
    Ramos-Filho AC; Moscoso JA; Calmasini F; Faria Jde A; Anhê GF; Mónica FZ; Antunes E
    Eur J Pharmacol; 2014 Sep; 738():285-92. PubMed ID: 24881522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
    Kjeldsen SE; Dahlöf B; Devereux RB; Julius S; Aurup P; Edelman J; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn S; Wedel H;
    JAMA; 2002 Sep; 288(12):1491-8. PubMed ID: 12243636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
    Dahlöf B; Devereux RB; Julius S; Kjeldsen SE; Beevers G; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Hypertension; 1998 Dec; 32(6):989-97. PubMed ID: 9856962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
    Pouleur AC; Uno H; Prescott MF; Desai A; Appelbaum E; Lukashevich V; Smith BA; Dahlöf B; Solomon SD;
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):483-90. PubMed ID: 21746765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
    Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
    Zhu BQ; Sievers RE; Browne AE; Lee RJ; Chatterjee K; Grossman W; Karliner JS; Parmley WW
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):31-7. PubMed ID: 12692751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Ulusoy S; Ozkan G; Orem C; Kaynar K; Koşucu P; Kiriş A
    Ren Fail; 2010; 32(8):913-7. PubMed ID: 20722556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.
    Boner G; Cooper ME; McCarroll K; Brenner BM; de Zeeuw D; Kowey PR; Shahinfar S; Dickson T; Crow RS; Parving HH;
    Diabetologia; 2005 Oct; 48(10):1980-7. PubMed ID: 16082528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
    Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise.
    Warner JG; Metzger DC; Kitzman DW; Wesley DJ; Little WC
    J Am Coll Cardiol; 1999 May; 33(6):1567-72. PubMed ID: 10334425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of captopril treatment of renovascular hypertension on beta-adrenergic modulation of L-type Ca(2+) current.
    Xu X; Rials SJ; Wu Y; Liu T; Marinchak RA; Kowey PR
    J Pharmacol Exp Ther; 2000 Jan; 292(1):196-200. PubMed ID: 10604948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Losartan: in the reduction of stroke risk in patients with hypertension and left ventricular hypertrophy.
    Waugh J; Keating GM
    Am J Cardiovasc Drugs; 2003; 3(5):371-7; discussion 378-9. PubMed ID: 14728071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.